Valoración de la Sexualidad de la Pareja Infértil (INFEXO)
Valoración de la Sexualidad de la Pareja Infértil: Estudio de Cohorte Prospectivo
The study hypothesis is that infertile couples experience an impact of their sexuality impacted during the diagnostic process carried out as part of the medically assisted procreation assessment, and also by the announcement of the possible cause of the couple's infertility. It is also conceivable that a disorder of the couple's sexuality forms the origin of, or is a contributor to, infertility.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Nîmes, Francia
- CHU de Nimes
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
80 heterosexual infertile couples (according to the WHO definition) followed at the Nîmes University Hospital in the Urology / Gynecology departments.
Descripción
Inclusion Criteria:
- Couple in which each of the two partners has signed the consent form which is presented separately and independently of their partner.
- The patient must be a member or beneficiary of a health insurance plan
- Heterosexual infertile couple (according to the WHO definition) monitored at the Nîmes University Hospital in the urology / gynecology departments.
Adult patient (≥18 years old) and under 43 years old for women, 60 years old for men
Exclusion Criteria:
- The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
- One member of the couple refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient without good level of written and spoken French
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Pareja infértil
|
Panel of questionnaires assessing sexuality, relationship satisfaction, and body image |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sexuality of the female of the couple
Periodo de tiempo: 2 weeks after inclusion (start of MAP)
|
Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 |
2 weeks after inclusion (start of MAP)
|
|
Sexuality of the female of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 |
1 month after ovarian ponction (end of MAP)
|
|
Sexuality of the male of the couple
Periodo de tiempo: 2 weeks after inclusion (start of MAP)
|
Male Sexual Health Questionnaire |
2 weeks after inclusion (start of MAP)
|
|
Sexuality of the male of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Male Sexual Health Questionnaire |
1 month after ovarian ponction (end of MAP)
|
|
Ejactulation of the male of the couple
Periodo de tiempo: 2 weeks after inclusion (start of MAP)
|
Premature Ejaculation Profile |
2 weeks after inclusion (start of MAP)
|
|
Ejactulation of the male of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Premature Ejaculation Profile |
1 month after ovarian ponction (end of MAP)
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sexuality of the female of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 |
1 month after ovarian ponction (end of MAP)
|
|
Sexuality of the male of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Male Sexual Health Questionnaire |
1 month after ovarian ponction (end of MAP)
|
|
Body satisfaction and global self-perception of both members of the couple
Periodo de tiempo: 2 weeks after inclusion (start of MAP)
|
Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100. |
2 weeks after inclusion (start of MAP)
|
|
Body satisfaction and global self-perception of both members of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100. |
1 month after ovarian ponction (end of MAP)
|
|
Relationship satisfaction of both members of the couple
Periodo de tiempo: 2 weeks after inclusion (start of MAP)
|
Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107 |
2 weeks after inclusion (start of MAP)
|
|
Relationship satisfaction of both members of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107 |
1 month after ovarian ponction (end of MAP)
|
|
Self-esteem of both members of the couple
Periodo de tiempo: 2 weeks after inclusion (start of MAP)
|
Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. |
2 weeks after inclusion (start of MAP)
|
|
Self-esteem of both members of the couple
Periodo de tiempo: 1 month after ovarian ponction (end of MAP)
|
Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. |
1 month after ovarian ponction (end of MAP)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Stéphanie Huberlant, CHU Nimes
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- NIMAO/2019-2/SH-01
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .